Science

paratek-pharmaceuticals-pipeline-omadacycline-sarecycline

Paratek is working to change how bacterial infections are treated. Currently, the intraveneous (IV) method is most common. However, this often limits patient treatment to a hospital or infusion center setting. A new class of antibiotics - aminomethylcyclines - may change how these treatments can be administered in both the hospital and community settings. Learn more about Omadacycline and Sarecycline.